From: A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer
Normal tissue dose-volume
Constraint
Rectum
V31 Gy
25%
V28 Gy
40%
V24 Gy
55%
V20 Gy
65%
Bladder
30%
50%
Femoral head
Maximum
28 Gy
Small intestine
24 Gy